A Rapid- and Short-Acting Hypoglycemic Agent KAD-1229 Improves Post-Prandial Hyperglycemia and Diabetic Complications in Streptozotocin-Induced Non-Insulin-Dependent Diabetes Mellitus Rats

スポンサーリンク

概要

論文の詳細を見る
1996-08-01

著者

関連論文

Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke
A Rapid- and Short-Acting Hypoglycemic Agent KAD-1229 Improves Post-Prandial Hyperglycemia and Diabetic Complications in Streptozotocin-Induced Non-Insulin-Dependent Diabetes Mellitus Rats
Low-Molecular-Weight Heparin (Dalteparin) Demonstrated a Weaker Effect on Rat Bone Metabolism Compared with Heparin
Dopamine Receptor Affinities in Vitro and Stereotypic Activities in Vivo of Cabergoline in Rats
CANINE CORONARY REPERFUSION MODEL AND THE INFLUENCE OF OKY-046, A SPECIFIC TXA_2 SYNTHETASE INHIBITOR : Ischemic Heart Disease (II), Coronary Circulation : II : 48 Annual Scientific Meeting, Japanese Circulation Society
Effects of KCA-012 on Bone Metabolism in Organ Culture
Studies on the Metabolic Fate of Cabergoline (III) : Identification of Liver Metabolites, Distribution of Brain, and Effect on Hepatic Drug-Metabolizing Enzymes in Rats
Studies on the Metabolic Fate of Cabergoline (II) : Absorption, Distribution and Excretion after Repeated Oral Administration to Rats, and Transfer into the Fetus and Milk of Rats
Studies on the Metabolic Fate of Cabergoline (I) : Absorption, Distribution, and Excretion after a Single Oral Administration to Rats
Tranilast Suppresses Intimal Hyperplasia in the Balloon Injury Model and Cuff Treatment Model in Rabbits
Mechanism f inhibitory action of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) in vitro: Effect of tranilast on the release of arachidonic acid and its metabolites.
Study of the mechanism of inhibitory action of tranilast on chemical mediator release.
Enzymatic study to characterize the slow reacting substance of anaphylaxis (SRS-A) and leukotrienes.
Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
Effects of KCA-098 on Bone Metabolism: Comparison with Those of Ipriflavone.
Inhibitory action of OKY-046HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor(PAF)-induced airway hyperresponsiveness of guinea pigs: Role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.
Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-(p-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid (OKY-046).

もっと見る

スポンサーリンク